Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia

被引：20

作者：

Yan, Yinfa ^{[1
]}

Zhou, Ping ^{[1
]}

Rotella, David P. ^{[1
]}

Feenstra, Rolf ^{[2
]}

Kruse, Chris G. ^{[2
]}

Reinders, Jan-Hendrik ^{[2
]}

van der Neut, Martina ^{[2
]}

Lai, Margaret ^{[3
]}

Zhang, Jean ^{[3
]}

Kowal, Dianne M. ^{[3
]}

Carrick, Tikva ^{[3
]}

Marquis, Karen L. ^{[3
]}

Pausch, Mark H. ^{[3
]}

Robichaud, Albert J. ^{[1
]}

机构：

[1] Wyeth Res, Chem Sci, Princeton, NJ 08543 USA

[2] Solvay Pharmaceut Res Labs, NL-1381 CP Weesp, Netherlands

[3] Wyeth Res, Discovery Neurosci, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 09期

关键词：

Serotonin reuptake inhibitor; Dopamine D-2 partial agonist; Schizophrenia; DEPRESSION; ARIPIPRAZOLE; COMBINATION; OLANZAPINE; FLUOXETINE;

D O I：

10.1016/j.bmcl.2010.02.105

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A dihydroquinolinone moiety was found to be a potent serotonin reuptake inhibitor pharmacophore when combined with certain amines. This fragment was coupled with selected D-2 ligands to prepare a series of dual acting compounds with attractive in vitro profiles as dopamine D-2 partial agonists and serotonin reuptake inhibitors. Structure-activity studies revealed that the linker plays a key role in contributing to D-2 affinity, function, and SRI activity. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：2983 / 2986

页数：4

共 50 条

[1] The Synthesis of a Dopamine D2 Partial Agonist for the Treatment of Schizophrenia
Magano, Javier
Acciacca, Alison
Akin, Anne
Collman, Benjamin M.
Conway, Brian
Waldo, Michael
Chen, Michael H.
Mennen, Kenneth E.
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (03) : 555 - 566
[2] Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia
Rotella, David P.
McFarlane, Geraldine R.
Greenfield, Alexander
Grosanu, Cristina
Robichaud, Albert J.
Denny, Rajiah Aldrin
Feenstra, Rolf W.
Nunez-Garcia, Sara
Reinders, Jan-Hendrik
van der Neut, Martina
McCreary, Andrew
Kruse, Chris G.
Sullivan, Kelly
Pruthi, Farhana
Lai, Margaret
Zhang, Jean
Kowal, Dianne M.
Carrick, Tikva
Grauer, Steven M.
Navarra, Rachel L.
Graf, Radka
Brennan, Julie
Marquis, Karen L.
Pausch, Mark H.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (19) : 5552 - 5555
[3] Which role for brexpiprazole, a new dopamine D2 partial agonist, in the treatment of schizophrenia?
Citrome, Leslie
EVIDENCE-BASED MENTAL HEALTH, 2016, 19 (02) : E6 - E6
[4] Palindore: A potent, selective D2/D3 partial agonist for the treatment of schizophrenia.
Stack, G
Marquis, K
Rosenzweig-Lipson, S
Mewshaw, RE
Bravo, B
Tran, M
Scerni, R
Brennan, J
Coupet, J
Spangler, T
Wasik, T
Shropshire, A
Piesla, M
Grauer, S
Uzzle, C
Andree, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U176 - U176
[5] Novel dopamine D2 partial agonists in the treatment of schizophrenia
Correll, C.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S668 - S668
[6] BREXPIPRAZOLE: A NEW DOPAMINE D2 RECEPTOR PARTIAL AGONIST FOR THE TREATMENT OF SCHIZOPHRENIA AND MAJOR DEPRESSIVE DISORDER
Citrome, L.
DRUGS OF TODAY, 2015, 51 (07) : 397 - 414
[7] Aripiprazole, a novel antipsychotic, is a potent partial agonist at human dopamine D2 receptors
Burris, KD
Molski, TF
Ryan, E
Xu, C
Tottori, K
Kikuchi, T
Yocca, FD
Molinoff, PB
SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 88 - 88
[8] Clozapine:: partial agonist at dopamine D2 receptors!
Ninan, I
Kulkarni, SK
PSYCHOPHARMACOLOGY, 1998, 138 (02) : 215 - 216
[9] Clozapine: partial agonist at dopamine D2 receptors!
I. Ninan
S. K. Kulkarni
Psychopharmacology, 1998, 138 : 215 - 216
[10] SLV310, a molecule combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition
Kruse, CG
Tuinstra, T
Herremans, A
van Vliet, B
Long, SK
van der Heijden, JA
Hesselink, MB
SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 110 - 110

← 1 2 3 4 5 →